BioMarin Pharmaceutical (BMRN) to Release Quarterly Earnings on Thursday
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) will likely be announcing its Q1 2025 earnings results after the market closes on Thursday, May 1st. Analysts expect the company to announce earnings of $0.95 per share and revenue of $741.84 million for the quarter. BioMarin Pharmaceutical has set its FY 2025 guidance at 4.200-4.400 EPS. BioMarin […]
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) will likely be announcing its Q1 2025 earnings results after the market closes on Thursday, May 1st. Analysts expect the company to announce earnings of $0.95 per share and revenue of $741.84 million for the quarter. BioMarin Pharmaceutical has set its FY 2025 guidance at 4.200-4.400 EPS. BioMarin […]
